Consolidated Portfolio Review Corp’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,391
Closed -$1.27M 286
2023
Q4
$1.27M Sell
22,391
-43,691
-66% -$2.44M 0.29% 94
2023
Q3
$3.69M Sell
66,082
-1,113
-2% -$63.3K 0.9% 22
2023
Q2
$3.87M Buy
67,195
+3,936
+6% +$232K 0.92% 22
2023
Q1
$3.83M Buy
+63,259
New +$3.96M 1.04% 20

Other funds holding CDC

Consolidated Portfolio Review Corp's CDC Position: Q1 2024 in Review

Consolidated Portfolio Review Corp sold out of VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) in Q1 2024, closing a stake of 22,391 shares — an estimated $1.27M sold.

Consolidated Portfolio Review Corp first reported a position in CDC in Q1 2023 and held it in 4 quarters. The position peaked at $3.87M in Q2 2023. 105 funds tracked by Wall St. Rank hold CDC as of Q1 2024.

  • Consolidated Portfolio Review Corp reported no remaining VictoryShares US EQ Income Enhanced Volatility Wtd ETF position as of Q1 2024 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 22,391 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q1 2024, an estimated $1.27M.
  • Consolidated Portfolio Review Corp first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q1 2023 and held it in 4 quarters.
  • Consolidated Portfolio Review Corp's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $3.87M in Q2 2023.
  • 105 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q1 2024.

Based on Consolidated Portfolio Review Corp's 13F filing for Q1 2024, filed 30 Apr 2024.